News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Allergan Inc. (AGN) Receives U.S. Subpoena Over Weight Loss Device



5/8/2012 7:57:49 AM

Allergan Inc. (AGN) (AGN), the maker of the wrinkle treatment Botox, received a U.S. government subpoena over its gastric banding device for obesity. Allergan received the subpoena from the Department of Health and Human Services’s Inspector General this month, the company reported today in a filing. Bonnie Jacobs, a spokeswoman for Irvine, California-based Allergan, acknowledged the subpoena but declined to comment further. Allergan generated $203.1 million of its $5.42 billion revenue (AGN) last year from devices for obesity. The company acquired the product, called Lap-Band, in 2006 with its purchase of Inamed Corp. The adjustable silicon band helps people lose weight by reducing the amount of food their stomachs can hold.

Read at BusinessWeek
Read at MSN
Read at News Release
Read at Wall Street Journal


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES